SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.4200
0.00 (0.00%)
Aug 6, 2026, 4:10 PM AEST
SomnoMed Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 118.5 | 111.49 | 91.65 | 83.62 | 72.58 | 62.71 |
Revenue Growth | 6.29% | 21.65% | 9.61% | 15.20% | 15.75% | 9.44% |
Gross Profit Gross Profit Growth | 70.87 | 66.73 | 55.13 | 51.92 | 44.28 | 37.74 |
Operating Income Operating Income Growth | 1.08 | -0.31 | -8.33 | -3.6 | -4.13 | -0.85 |
Net Income Net Income Growth | -2.56 | -3.46 | -12.24 | -8 | -4.44 | -1.19 |
Earnings Per Share EPS Growth | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
North America (Excl. North America (RSS Component)) North America (Excl. North America (RSS Component)) Growth | 45.7 | 43.23 | 32.94 | 30.33 | 24.83 | 18.56 |
Europe Europe Growth | 67.83 | 62.7 | 54.17 | 48.89 | 43.52 | 40.09 |
Asia Pacific Asia Pacific Growth | 27.59 | 26.23 | 21.74 | 18.16 | 15.45 | 13.33 |
Intersegment Eliminations Intersegment Eliminations Growth | -22.62 | -20.67 | -17.21 | -13.77 | -11.22 | -9.28 |
Total Total Growth | 118.5 | 111.49 | 91.65 | 83.62 | 72.58 | 62.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 18.03 | 17.29 | 16.18 | 11.96 | 15.64 | 21.11 |
Total Debt Total Debt Growth | 6.61 | 8.03 | 6.72 | 23.51 | 12.01 | 8.91 |
Net Cash (Debt) Net Cash Growth | 11.42 | 9.27 | 9.46 | -11.55 | 3.63 | 12.2 |
Net Cash Growth | 23.17% | -2.02% | - | - | -70.22% | -16.68% |
Net Cash Per Share Net Cash Per Share Growth | 0.05 | 0.04 | 0.08 | -0.15 | 0.05 | 0.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 7.85 | 7.78 | -6.03 | -3.88 | 1.86 | 2.71 |
Capital Expenditures CapEx Growth | -4.15 | -2.42 | -1.39 | -3.14 | -1.01 | -2.15 |
Free Cash Flow Free Cash Flow Growth | 3.71 | 5.36 | -7.42 | -7.02 | 0.85 | 0.55 |
Free Cash Flow Growth | -30.90% | - | - | - | 53.94% | -83.90% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 59.81% | 59.85% | 60.15% | 62.09% | 61.01% | 60.19% |
Operating Margin | 0.91% | -0.28% | -9.09% | -4.31% | -5.69% | -1.36% |
Pretax Margin | -0.14% | -0.69% | -12.30% | -8.43% | -4.82% | -1.17% |
Profit Margin | -2.16% | -3.10% | -13.36% | -9.57% | -6.11% | -1.90% |
FCF Margin | 3.13% | 4.81% | -8.10% | -8.39% | 1.17% | 0.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Forward PE | 20.10 | 108.33 | 84.02 | 85.27 | 175.36 | 62.78 |
P/FCF Ratio | 24.83 | 26.20 | - | - | 117.89 | 331.46 |
PS Ratio | 0.78 | 1.26 | 0.60 | 0.95 | 1.38 | 2.92 |